FTC on First Amendment
This article was originally published in The Tan Sheet
Executive Summary
Consumers would benefit if FDA "expanded its use of regulatory approaches that allow the dissemination of truthful and non-misleading claims about the nutrient content and health benefits of foods," state 1FTC staff comments on FDA's application of the First Amendment. Commission staff suggest a "flexible approach" to commercial speech, rather than broad restrictions. "Advertising and labeling can be extremely effective tools to educate consumers about diet-disease relationships, to increase their awareness of diseases, to inform them of different treatment options and to empower them to manage better their own health," commission staff say. FTC's comments do not address the constitutionality of any specific FDA regulation or practice, or suggest revisions to its regulatory framework...
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.